October 08, 2012

Avanir Pharmaceuticals Inc. v. Impax Laboratories Inc.

Track this case

Case Number:

1:12-cv-01298

Court:

Delaware

Nature of Suit:

Patent

Judge:

Unassigned Judge

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 09, 2012

    Avanir Targets Impax Over Generic Nuedexta Plans

    Avanir Pharmaceuticals Inc. on Monday sued rival Impax Laboratories Inc. in Delaware federal court, claiming Impax's plans to make a generic version of involuntary-emotion drug Nuedexta infringe one of its patents.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!